CS Paper Radar

PRISMATIC : Prescription Risk Inspection System for Multi-Agent Treatment Interaction in Clinical Decision-Making

Ziyang Ling, Shuyu Lu, Ziyi Chen

cs.CL cs.AI ·submitted 2026-10-14 08:17 UTC · v1
hot direction

Abstract

Medical prescribing errors for multimorbid patients, who require complex drug regimens, are a major patient safety concern. These errors often stem from fragmented decision-making across medical specialties, a critical coordination failure that leads to adverse drug events and rehospitalizations. To address this coordination challenge, we introduce PRISMATIC, a multi-agent architecture where specialized agents, each representing a workflow role, collaboratively generate and refine treatment plans. Operating on a blackboard architecture, the system first structures patient information from clinical notes, then iteratively develops safe, rational, and interpretable drug regimens. The agents' collaboration is governed by two novel adaptive coordination mechanisms: (1) Dynamic Self-Updating Weight Adjustment (DSWA), a long-term mechanism that adjusts the influence weights of agents based on historical case outcomes, enabling the system to adapt and trust more reliable specialists over time. (2) Discrepancy Feedback Precise Calibration (DFPC), a short-term mechanism where agents provide iterative feedback to resolve disagreements and eliminate prescription conflicts for the current patient. Experiments on patient records from the MIMIC-IV database show that PRISMATIC significantly reduces drug conflicts, improves prescription coverage, and enhances treatment consistency compared to strong LLM baselines. Our work demonstrates that structuring clinical co-treatment as a multi-agent coordination problem offers a promising path toward safer and more coherent multidisease management.

Closest papers

Nearest neighbours by meaning across the whole index.

Coupled Graph--Policy Distillation for Personalized Medication Safety in Older Adults with Multimorbidity

cs.AI ·2026-08-10 ·Zihan Wang, Anglin Liu, Rongyi Wang, Dantong Li, Yi Lu +4 more
benchmark similarity 0.69
Abstract

Large language model (LLM) agents can support medication review between clinical visits, but safe choices for older adults with multimorbidity depend on conditions, medications, and geriatric risks that users may omit. We introduce ATLAS, a coupled graph--policy distillation framework for patient-adaptive medication safety. ATLAS structures guideline evidence as a medication-safety graph. Targeted questions update the patient state and distill relevant relations into a patient-specific medication conflict graph (PMCG). A risk-first multi-agent policy uses the PMCG to screen contraindications, assess cautions and monitoring needs, identify safer alternatives, and verify the final medication plan. We also introduce GeriMedBench, an interactive benchmark that tests safety-critical information acquisition and evidence-based decision revision. Across a European non-interactive multimorbidity benchmark, an Asian interactive multimorbidity benchmark, and an Asian non-interactive cross-guideline benchmark, ATLAS achieves the strongest complete-decision performance among the compared systems. On the European non-interactive multimorbidity benchmark, it exceeds the strongest proprietary LLM baseline by 53.73 points in Strict Success Rate and 14.63 points in overall safety reasoning score (OSRS), with no unsafe recommendations under the automated evaluator. A blinded clinician evaluation gives ATLAS higher mean ratings across all five criteria and flags potentially unsafe recommendations in one ATLAS case and two Gemini cases.

0.04

HEM-Med: A Hierarchical Agentic Memory Framework for Safe Multi-Center Medication Recommendation

cs.AI cs.IR ·2026-10-14 ·Min Xiao, Jin Li, Shoujin Wang, Yeguang Zhen, Yishuo Li +1 more
similarity 0.67
Abstract · BIBM 2026

Medication recommendation (MR) is critical for clinical decision support. While existing MR methods are mostly designed for single-center learning, where only one independent hospital is involved, multi-center MR with hospitals of different scales has become increasingly demanding in practice. In multi center settings, abundant data from large medical centers can improve recommendation performance for low-resource centers. Despite a few preliminary attempts on this task, two critical gaps remain. Gap 1: Existing multi-center methods fail to disentangle transferable cross-hospital clinical experience from hospital-specific prescribing patterns, limiting clinical feasibility and physician acceptance. Gap 2: They commonly overlook multi label safety constraints of MR, including drug-drug interaction risks and local formulary feasibility, which are essential for safe real-world deployment. To address these gaps, we propose HEM-Med, a novel hierarchical agentic memory framework for multi-center MR. To address Gap 1, we design a disentangled hierarchical memory module that builds patient-level medication context attribution records and disentangles them into cross hospital experience memory and hospital-specific residual memory. To address Gap 2, we introduce a safety-aware medication set generation module, which integrates dual-level experience retrieval with safety-aware set decoding to produce clinically relevant, safer, and locally adaptive medication recommendations. Experiments on a real-world multi-center eICU dataset show that HEM-Med outperforms representative transfer learning, LLM-based, and MR baselines in terms of both recommendation accuracy and safety.

0.07

VITAL: A Framework for Validating Agentic AI in Pharmaceutical Drug Development and Clinical Trial Operations

cs.AI ·2026-11-17 ·Sandeep Burugupalli, Pedro Matos-Filipe, Andrea Hita Ardiaca, Adam Taylor, Alex Grigorenko +8 more
similarity 0.66
Abstract

Current assurance approaches do not establish whether evidence is sufficient to validate, monitor and govern agentic artificial intelligence (AI) within a pharmaceutical context of use. Plausible outputs may conceal failures in retrieval, reasoning, orchestration or human-control points, where reference standards are unavailable. We developed and operationalised VITAL (Validation by Intended use, Traceability, Autonomy and Lifecycle evidence), a validation framework for agents in clinical development, through landscape analysis, regulatory and standards mapping, expert interviews and multi-stakeholder refinement. VITAL integrates context of use, controls, behavioural validation and lifecycle evidence within a risk-adjusted framework. We applied VITAL across epidemiology and treatment-landscape analysis, site selection, enrolment rescue and trial-design trade-off support to translate autonomy, reversibility, transparency and patient impact into proportionate validation activities, evidence requirements and auditable reconstruction of system behaviour. VITAL may inform evidence requirements and lifecycle accountability for higher-risk pharmaceutical uses; evaluation should assess reproducibility across assessors, organisations and system configurations.

0.33

Governed AI-Agent Coordination for Dementia Care: Architecture, Safety Contracts, and Evidence-Derived Workflow Verification

cs.MA ·2026-09-22 ·Francesca Medda, Hui Gong
similarity 0.65
Abstract · 16 pages, 2 figures, 6 tables. Includes an executable architecture-verification harness with 18 requirement-derived traces and six component…

Dementia care at home increasingly involves connected sensors, medication devices, electronic records, and assistive technologies. Professionals and family carers must still interpret these observations, reconstruct context, coordinate responses, and verify resolution. Sustaining safe care at home while ensuring timely clinical escalation requires continuity between these tasks. Agentic engineering creates a systems opportunity by combining model interpretation with persistent external memory, planning, authorised tool use, and outcome feedback. This paper presents Governed Closed-loop Agent Coordination (GCAC), an architecture for bounded agent participation in community dementia-care workflows. Evidence on coordination failures and policy obligations is translated into traceable system requirements. GCAC separates observation, four governed memory classes, planning, deterministic policy enforcement, execution, and outcome monitoring through a typed event-memory-decision-action-outcome contract. A worked medication-device example explains how these roles maintain context, allocate responsibility, and distinguish an unrecorded dose from a clinically established omission. A reference harness evaluates 18 evidence-derived traces spanning care gaps, service failure, consent change, stale state, duplicate events, untrusted text, and acute-change routing. GCAC satisfies all 18 contract oracles with zero policy-violating tool calls; event-threshold and stateless-planner controls satisfy 2/18 and 1/18, respectively. Six ablations identify the contribution of memory, policy, and versioning. The results establish architectural conformance. Effects on hospital use, quality of life, staff workload, unpaid care, and net costs require prospective evaluation. GCAC provides a testable basis for accountable coordination that preserves human authority over consequential care decisions.

0.24

MedHarnessBench: A Unified Benchmark for Healthcare Agent Evaluation

cs.AI ·2026-10-11 ·Rui Tang, Hongqiu Wang
benchmarkcode/data similarity 0.64
Abstract

Healthcare agents must transform longitudinal clinical evidence into reliable actions through heterogeneous tools and stateful workflows, conditions under which model-centric systems may lose context, misuse tools, fail to verify consequential transitions, or cross authorization boundaries. Existing medical-agent benchmarks primarily emphasize terminal task outcomes, making it difficult to determine whether execution failures arise from the agent model, the runtime harness, or their interaction. We present the Medical Harness Protocol, an outcome-preserving framework that independently evaluates seven healthcare-specific process dimensions: Care Action Fulfillment, Clinical Resource Competence, Patient-Evidence Alignment, Clinical Workflow Continuity, Clinical Auditability, Closed-Loop Verification, and Clinical Conduct Boundaries. A normalized intervention trace further tracks whether runtime support is available, activated, delivered, adopted by the agent, and propagated into subsequent behavior. We instantiate the protocol as MedHarnessBench, comprising 342 executable tasks across FHIR/EHR operations, healthcare-administration interfaces, and multimodal clinical tools. Across more than 16,000 controlled task executions, MedHarness yields broad improvements in terminal task success, intermediate subtask completion, and healthcare-specific process quality. We further evaluate MedHarness against multiple general-purpose harnesses and use controlled single-fault perturbations to verify the sensitivity and discrimination of the seven-dimensional evaluation. These results demonstrate that healthcare-specific runtime support can substantially improve both task completion and execution quality, while revealing failures that terminal outcomes alone cannot capture. Code and resources are available at https://github.com/Tomry1114/Awesome-Agent-Harness-for-Healthcare.

0.20

More Reasoning Is Not Always Better: Executing Clinical Guidelines with LLMs and Rules

cs.CL ·2026-10-11 ·Xiaoqian Lu, Guangfu Guo, Long Cheng, Kunpeng Liu
similarity 0.63
Abstract

Large language models (LLMs) have shown considerable promise in clinical decision support. However, existing approaches often rely on multi-step reasoning or multi-agent collaboration to execute clinical guidelines, introducing substantial computational overhead without reliably preventing decision errors. To address these limitations, we propose a framework for Medical Decision Execution (MedDEx) that integrates structured patient states with deterministic rule execution to support guideline-based treatment planning. MedDEx separates clinical record interpretation from guideline execution, leveraging LLMs to extract patient information and generate treatment plans while assigning guideline-defined decision logic to a rule executor. Experiments across multiple clinical guideline benchmarks demonstrate that MedDEx improves decision accuracy while reducing inference costs. Further analyses highlight the critical roles of structured patient representations and deterministic rule execution, suggesting that additional LLM reasoning does not necessarily translate into better guideline adherence.

0.16

Disparity Laundering: Consensus Without Fairness in Clinical Multi-Agent Systems

cs.AI cs.MA ·2026-10-28 ·Xiaoyang Wang, Tianrui Wang, Christopher C. Yang
publishedcode/data similarity 0.63
Abstract · 21 pages, 8 figures. Code: https://github.com/wangxiaoyang0412/disparity-laundering . Committed to EACL 2027

Clinical large language models are increasingly fielded as multi-agent teams, on the assumption that deliberation averages out individual error. It does not average out bias. Across a full factorial of five model families and four aggregation topologies on 120 real MIMIC-IV emergency cases under counterfactual demographic swaps, no configuration neutralizes the disparity: all 20 cells commit the direction of their agents' independent answers, giving Black patients more acute triage. Every model has a topology that amplifies its baseline gap, but which one varies by model, so no design is reliably safe or reliably amplifying: the disparity is relocated, never removed. Late-stage fixes fail: fairness instructions and demographic masking leave the gap untouched, and per-agent self-debiasing widens it, because the bias is already encoded in the agents' ordinary clinical numbers. We call this disparity laundering; the audits now applied to clinical AI, per model, per output, per version, can certify the parts but never the committed decision. Interventions close the gap exactly when they make counterfactual versions visible inside the system and pool them, through deliberation, into the committed decision. A diverse-perspective ensemble does both while keeping the team, with no retraining or architectural change: the disparity falls by 67 to 94% where all five perspectives pool at every round, and the one topology that never pools them is the one it cannot reliably repair. Medical multi-agent systems do not filter demographic bias; they launder it into plausible decisions no single-version audit can catch, and the only defense is to make the bias visible.

0.41

BioMed-Agent-RL: A Meta Learning, All You Need for Biomedical Applications

cs.LG cs.AIcs.CV ·2026-08-22 ·Md Asaduzzaman Jabin, Zihao Wu, Tianming Liu
hot direction similarity 0.62
Abstract

The current progress of Clinical Vision Large Language Models (C-VLLMs) has substantially improved digital diagnostics, still these frameworks often endure lesion noises, modality misalignment, hallucination, and missed contextual grounding in complex clinical cases. Moreover, prevailing agent systems usually depend on static and non-adaptable pipelines and lack the versatility necessary for complex medical reasoning. To resolve these difficulties, we present BioMed-Agent-RL, a unified medical agent that incorporates adaptive orchestration, policy, and reward-based reinforcement learning (RL) models for biomedical applications. To ensure reliability, it invokes clinical context-aware preference optimization (CPO), direct preference optimization (DPO), and group relative policy optimization (GRPO) with dynamic entropy regulation. This pipeline utilizes a multimodal meta-learning approach that operates as a field-specific expert and human judgment synthesizer. The agent adaptively utilizes a set of model-level expertise, such as clinical grounding and reasoner, lesion segmenter, and field-specific synthesizer, across various clinical modalities (e.g., X-ray) by utilizing an iterative and adaptive RL approach. The agent learns to seriously synthesize misleading, conflicting vision cues and trust in inherent reasoning, while specialist advice is faulty. An intensive ablation study is conducted across multiple benchmarks, and the agent significantly outperforms existing state of the art models, such as GPT-5, attaining up to ~73% accuracy (gain of ~5%) over contemporary baselines. As a result, the framework suggests a new standard for building factual, reliable, robust, and expert-like intelligent agent systems for independent clinical reasoning.

0.23